Targeted therapy of ESBL infections and other resistant gram negative infections.
Empiric therapy when broad spectrum of carbapenems is desired without the need for anti-pseudomonal activity.
Carbapenems may cause rapid and profound decrease in valproic acid levels. Increasing valproic acid dosage is often NOT sufficient to overcome this interaction. Avoid this combination if at all possible.
IV Administration
N/A
Antimicrobial class: Carbapenem
Pregnancy category: B
Average serum half life: 4 hours
Biliary penetration: Moderate
Lung penetration: Therapeutic
Urine penetration: Therapeutic